Skip to main content
Clinical Trials/TCTR20240806006
TCTR20240806006
Completed
Phase 3

Outcome and comparison between transepithelial photorefractive keratectomy and photorefractive keratectomy using Manual Superficial keratectomy

Armed force medical services0 sites80 target enrollmentAugust 6, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Refractive error requiring refractive surgery
Sponsor
Armed force medical services
Enrollment
80
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2024
End Date
May 1, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. aged 21 to 45 years
  • 2\. Normal Slit lamp examination, with no appearing pathology.
  • 3\. Spherical equivalent power of \-1\.0 to \-5\.0 diopters.
  • 4\. Stable refraction with spectacles for the last 12 months before surgery.
  • 5\. Normal Pentacam parameters with no suspicious ectasia.
  • 6\. The thinnest pachymetry should not be less than 500 microns.
  • 7\. The final residual stromal bed thickness should be 400 microns and above including the original epithelium
  • 8\. best corrected distance visual acuity of 0\.8 Snellen chart or better for each eye.

Exclusion Criteria

  • 1\. Eyes with any pre\-existing corneal layer pathology (keratoconus, ocular inflammation, glaucoma, past ocular history of any surgery or posterior segment pathology).
  • 2\. Medication history of (isotretinoin, amiodarone, anticoagulants, HRT, antihistamine, sumatriptan).

Outcomes

Primary Outcomes

Not specified

Similar Trials